Dr. Lal PathLabs Limited
LALPATHLAB
Classement en actions
#4526
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Prix de l'action
$20.35
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$3.40B
Changement (1 jour)
-0.86%
Changement (1 an)
13.63%
Pays
IN
Échange Dr. Lal PathLabs Limited (LALPATHLAB)
Catégorie
Healthcare
Bénéfices pour Dr. Lal PathLabs Limited (LALPATHLAB)
Bénéfices en Jun 2026 TTM : $79.09M
Selon les derniers rapports financiers de Dr. Lal PathLabs Limited, les bénéfices actuels de l'entreprise sont de $79.09M. En 2024, l'entreprise a réalisé un bénéfice de $60.62M, une augmentation par rapport à celui de 2023 qui était de $41.84M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Dr. Lal PathLabs Limited de 2011 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $79.09M | 8.27% |
| 2025 | $73.05M | 20.51% |
| 2024 | $60.62M | 44.89% |
| 2023 | $41.84M | -33.14% |
| 2022 | $62.57M | 16.14% |
| 2021 | $53.88M | 30.72% |
| 2020 | $41.22M | -4.77% |
| 2019 | $43.28M | 7.84% |
| 2018 | $40.13M | 9.90% |
| 2017 | $36.52M | 20.54% |
| 2016 | $30.30M | 35.31% |
| 2015 | $22.39M | -3.94% |
| 2014 | $23.31M | 57.92% |
| 2013 | $14.76M | 12.68% |
| 2012 | $13.10M | 30.51% |
| 2011 | $10.04M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.61B | 9,520.18% |
US
|
|
| $4.76B | 5,920.67% |
US
|
|
| $-252.70M | -419.49% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,996.24% |
US
|
